| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/28/2002 | WO2002024659A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists |
| 03/28/2002 | WO2002024658A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 03/28/2002 | WO2002024657A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 03/28/2002 | WO2002024655A1 Isoquinolinone potassium channel inhibitors |
| 03/28/2002 | WO2002024653A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | WO2002024651A1 A process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs |
| 03/28/2002 | WO2002024650A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/28/2002 | WO2002024649A1 Substituted amino-aza-cycloalkanes useful against malaria |
| 03/28/2002 | WO2002024646A1 Delta1-pyrrolines used as pesticides |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | WO2002024629A1 Zwitterionic tachykinin receptor antagonists |
| 03/28/2002 | WO2002023986A1 4-acylaminopyrazole derivatives |
| 03/28/2002 | WO2001087831A3 Novel amorphous form of omeprazole salts |
| 03/28/2002 | WO2001080844A3 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| 03/28/2002 | WO2001077075A3 Inhibitors of inflammation and reperfusion injury |
| 03/28/2002 | WO2001068604A3 3-substituted piperidines comprising urea functionality, and methods of use thereof |
| 03/28/2002 | WO2001064676A3 INHIBITORS OF p38-α KINASE |
| 03/28/2002 | WO2001064631A3 Derives de polyfluoroalkylimidazole et leur utilisation en tant qu'antagonistes des recepteur muscariniques m3 et serotoniques 5-ht4 |
| 03/28/2002 | WO2001022954A3 Indolyl-3-glyoxylic acid derivatives serving as antitumor agents |
| 03/28/2002 | US20020038032 Orally administrable acid stable antiulcer benzimidazole derivatives |
| 03/28/2002 | US20020038030 For therapy of inflammatory conditions including migraine, rheumatoid arthritis, asthma, and inflammatory bowel disease as well as mediation of the emetic reflex and the modulation of central nervous system (CNS) disorders such as Parkinson's |
| 03/28/2002 | US20020037924 Small molecule carbamate or urea hair growth compositions and uses |
| 03/28/2002 | US20020037907 Substituted 2- (S) -hydroxy-3- (piperidin-4-yl-methylamino) -propyl ethers and substituted 2-aryl-2- (R) - hydroxy-1- (piperidin-4-yl-methyl) -ethylamine beta-3 adrenergic receptor agonists |
| 03/28/2002 | US20020037905 N-phenyl-N'-(2-carboxyphenyl) urea, for example; chloride channel blockers; such as for treating bone metabolic disorders |
| 03/28/2002 | US20020037904 Substituted 4,9-dihydrocyclopent a [imn] phenanthridine-5-ones, derivatives thereof and their uses |
| 03/28/2002 | US20020037900 Hydroxamic acid derivatives |
| 03/28/2002 | US20020037897 Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
| 03/28/2002 | US20020037896 Bicyclic compounds |
| 03/28/2002 | US20020037895 Wherein the lactone ring is modified; preventing or treating disorders or diseases mediated by LFA-1 (Leukocyte Function-associated Antigen-1) ICAM-1 (intercellular adhesion molecules) interactions; autoimmune disorders, inflammation |
| 03/28/2002 | US20020037889 Imidazolidin-2-one derivatives; inhibiting bone resorption, vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, arthritis, viral disease, cancer and metastatic tumor growth |
| 03/28/2002 | US20020037888 4-imidazol-1-ylmethyl-2-(2-(2-oxo-piperidin-1-yl)-phenoxy) -benzonitrile for example; farnesyl-protein transferase inhibitors; treating cancer, benign proliferative disorder, hepatitis virus, restenosis, and polycystic kidney disease |
| 03/28/2002 | US20020037886 Muscarinic agonists |
| 03/28/2002 | US20020037878 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/28/2002 | US20020037856 Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 03/28/2002 | US20020037852 Anticarcinogenic agents |
| 03/28/2002 | US20020037534 Combinatorial preparation of a substance library with removal of a zwitterionic compound by precipitation |
| 03/28/2002 | CA2423356A1 Zwitterionic tachykinin receptor antagonists |
| 03/28/2002 | CA2423315A1 Substituted amino-aza-cycloalkanes useful against malaria |
| 03/28/2002 | CA2423154A1 Imidazole derivatives as raf kinase inhibitors |
| 03/28/2002 | CA2423106A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | CA2423050A1 Pyrazine derivatives as modulators of tyrosine kinases |
| 03/28/2002 | CA2422923A1 Pyridine derivatives with ikb-kinase (ikk-.beta.) inhibiting activity |
| 03/28/2002 | CA2422488A1 4-amino-quinazolines |
| 03/28/2002 | CA2421823A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 03/27/2002 | EP1191025A1 Crystals of benzimidazole compounds |
| 03/27/2002 | EP1191022A1 Novel dihydropyridine derivative |
| 03/27/2002 | EP1190721A2 A method for the anhydrous loading of nicotine onto ion exchange resins |
| 03/27/2002 | EP1189899A1 Pyrazinone thrombin inhibitors |
| 03/27/2002 | EP1189893A2 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one |
| 03/27/2002 | EP1189890A1 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 03/27/2002 | EP1189889A1 Compositions and methods for inhibiting cell death |
| 03/27/2002 | EP1189883A2 Substituted pyrrolidines as cell adhesion inhibitors |
| 03/27/2002 | EP1189875A2 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 03/27/2002 | EP1189628A1 Combination of tumor necrosis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
| 03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
| 03/27/2002 | EP1189609A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics |
| 03/27/2002 | EP0873336B1 Antagonists of gonadotropin releasing hormone |
| 03/27/2002 | EP0840607B1 Novel medical use |
| 03/27/2002 | EP0820287B1 Thrombin inhibitors |
| 03/27/2002 | EP0651746B1 Drugs that enhance synaptic responses mediated by ampa receptors |
| 03/27/2002 | CN1342158A 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists |
| 03/27/2002 | CN1342157A Substituted pyrazoles ASP38 kinase inhibitors |
| 03/27/2002 | CN1342149A Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 03/27/2002 | CN1342147A NItroxyderivatives having antiinflammatory, analgesic and antithrombotic activity |
| 03/27/2002 | CN1342145A Fused-ring compounds and use thereof as drugs |
| 03/27/2002 | CN1342140A 硫代酰胺衍生物 Thioamide derivatives |
| 03/27/2002 | CN1342074A Antidepressant heterocyclic compounds |
| 03/27/2002 | CN1341594A Substituted pyrrolidone, thiazolidone or oxazolidone as herbicide |
| 03/27/2002 | CN1341593A Proteinase inhibitor |
| 03/27/2002 | CN1341592A Proteinase inhibitor |
| 03/27/2002 | CN1341590A Proteinase inhibitor |
| 03/27/2002 | CN1081635C Substituted pyrrolidine-3-Yl-alkyl-piperidines |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362351 Catalyst and method for amide formation |
| 03/26/2002 | US6362338 Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia |
| 03/26/2002 | US6362337 Substituted phenyluracils |
| 03/26/2002 | US6362336 Administering a quinazoline derivative to a warm-blooded animal for producing an antiangiogenic and/or vascular permeability reducing effect |
| 03/26/2002 | US6362230 Alzheimer's disease |
| 03/26/2002 | US6362216 Antiinflammatory agents |
| 03/26/2002 | US6362201 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity |
| 03/26/2002 | US6362199 Central nervous system disorders; psychological disorders |
| 03/26/2002 | US6362198 Anticholesterol, antilipemic agent |
| 03/26/2002 | US6362196 Method to treat pain utilizing benzimidazole NMDA/NR2B antagonists |
| 03/26/2002 | US6362195 Inhibitor of nitric oxide synthase; central nervous system disorders |
| 03/26/2002 | US6362192 2-(Pyrazolyloxy) -pyridin-3-ylacetic acid derivatives, agents containing the same and use thereof against noxious fungi and animal parasites |
| 03/26/2002 | US6362190 Administering compounds such as 3-(2-phenylethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene -carboxamidomethylpyridi nyl)-2-pyrazinone, n'-((1-(aminoiminomethyl)4-piperidinyl) methyl)-n-(3,3-diphenylpropionyl)-l-proline amide |
| 03/26/2002 | US6362188 Farnesyl protein transferase inhibitors |
| 03/26/2002 | US6362181 Bactericides; enzyme inhibitors; antitumor agents |
| 03/26/2002 | US6361920 Photographic material containing a novel hydrazide type |
| 03/26/2002 | US6361571 Using tautomeric nonoxidative dyes and polymethine dyes |
| 03/26/2002 | CA2137953C Benzenesulfonamide derivative and process for preparing thereof |
| 03/26/2002 | CA2094703C Substituted piperazines as central nervous system agents |
| 03/26/2002 | CA2063030C Substituted n-phenylpiperidines and drugs therefrom |
| 03/21/2002 | WO2002022694A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 03/21/2002 | WO2002022611A2 Caspase inhibitors and uses thereof |
| 03/21/2002 | WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022605A1 Pyrazole compounds useful as protein kinase inhibitors |